Nevro Lands $58,000,000 New Financing

  • Feed Type
  • Date
    7/20/2011
  • Company Name
    Nevro
  • Mailing Address
    4040 Campbell Avenue Menlo Park, CA 94025
  • Company Description
    Nevro is a medical device company developing novel neuromodulation therapies for multiple indications. The company’s initial focus is the development of an implantable device for the treatment of chronic pain.
  • Website
    http://www.nevrocorp.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $58,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    The funds will be used to sponsor a pivotal clinical study in the U.S. and provide continued support for the company’s international commercialization strategy.
  • M&A Terms
  • Venture Investor
    Johnson & Johnson Development Corporation
  • Venture Investor
    Aberdare Ventures
  • Venture Investor
    Three Arch Partners
  • Venture Investor
    Bay City Capital
  • Venture Investor
    Accuitive Medical Ventures
  • Venture Investor
    Mayo Medical Ventures
  • Venture Investor
    MPM Capital

By posting a comment, you agree to our terms and conditions.